Efficacy of Alprostadil Injection for Acute Cerebral Infarction and Its Effects on Mean Platelet Volume and Plasma Fibrinogen
Qingsong Wang
Abstract
Qingsong Wang
Abstract
OBJECTIVE:To observate the effects of alprostadil injection for acute cerebral infarction and on mean platelet volume(MPV) and plasma fibrinogen level.METHODS: 120 patients with acute cerebral infarction were randomly divided into either control group(n=60) receiving conventional therapy or treatment group(n=60) treated with add-on alprostadil injection(10 μg once a day) by intravenous drip infusion.The therapeutic efficacy,MPV and plasma fibrinogen level were evaluated at 0 and 14 days,respectively.RESULTS: The excellent response rate in the treatment group was significant higher than in the control group(46.66% vs.21.67%) and the differences were statistically significant(P0.05).After treatment,the treatment group showed significantly greater reduction in MPV and plasma fibrinogen than did the control group(P0.05 for both).CONCLUSION: Alprostadil may improve hypercoagulable state by reducing the mean platelet volume and plasma protein fibrinogen level,and it plays a positive role in the treatment of patients with cerebral infarction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To observate the effects of alprostadil injection for acute cerebral infarction and on mean platelet volume(MPV) and plasma fibrinogen level.METHODS: 120 patients with acute cerebral infarction were randomly divided into either control group(n=60) receiving conventional therapy or treatment group(n=60) treated with add-on alprostadil injection(10 μg once a day) by intravenous drip infusion.The therapeutic efficacy,MPV and plasma fibrinogen level were evaluated at 0 and 14 days,respectively.RESULTS: The excellent response rate in the treatment group was significant higher than in the control group(46.66% vs.21.67%) and the differences were statistically significant(P0.05).After treatment,the treatment group showed significantly greater reduction in MPV and plasma fibrinogen than did the control group(P0.05 for both).CONCLUSION: Alprostadil may improve hypercoagulable state by reducing the mean platelet volume and plasma protein fibrinogen level,and it plays a positive role in the treatment of patients with cerebral infarction.
Key concepts: Fibrinogen, Medicine, Mean platelet volume, Platelet, Cerebral infarction, Anesthesia, Internal medicine, Cardiology